Cayman Journal - Spyre Therapeutics Inc (SYRE)

ARS — Spyre Therapeutics, Inc.

Fri, 10 Apr 2026 00:00:00 GMT

# 🔍 First, A Quick Reality Check Hello! I've got your request to summarize the SEC filing for Spyre Therapeutics (SYRE). However, the document text you provided is just a placeholder (`` tag) with **no actual filing content** inside it. An ARS (Annual Report to Shareholders) is typically a co

DEF 14A — Spyre Therapeutics, Inc.

Fri, 10 Apr 2026 00:00:00 GMT

# 🧾 What This Document Is This is a **DEF 14A**, also known as a **Proxy Statement**. Think of it as an invitation and instruction manual for a company's annual shareholder meeting. Spyre Therapeutics is asking its owners (the shareholders) to vote on several important company decisions. It outline